Creative Biolabs provides integrated probiotic and live biotherapeutic product research services that connect strain strategy, discovery, characterization, engineering, process development, formulation, quality control, stability, safety, efficacy, and mechanism studies in one coordinated program. Our stage-gated approach converts fragmented results into coherent, decision-ready packages for preclinical advancement, pre-IND preparation, partner review, and efficient next-step planning.
Probiotic and LBP teams often generate promising strain, function, process, and preclinical results through separate vendors. The resulting evidence may be scientifically useful but difficult to compare, trace, or assemble into a coherent development story. Early teams need a unified route that links candidate identity and intended function with manufacturability, formulation, quality attributes, safety, efficacy, and mechanism-of-action questions.
Creative Biolabs is a contract research organization supporting microbiome-focused biotechnology companies, pharmaceutical teams, and emerging programs across this connected lifecycle. We align work packages around program objectives, stage gates, and practical decisions, helping clients reduce handoff risk and turn distributed experiments into coordinated evidence for preclinical planning, pre-IND preparation, and IND-enabling study design.
We provide an end-to-end research framework in which each service can stand alone or connect to a broader development plan. Scope, acceptance criteria, and handoffs are defined early so every dataset supports a clear candidate, process, quality, or preclinical decision.
Build a defensible candidate shortlist through sourcing strategy, isolation or screening, taxonomic identification, genomic analysis, phenotype profiling, and functional characterization. Outputs can include strain identity records, comparative data, candidate ranking logic, and recommended follow-up studies tied to the target product profile.
Explore Discovery & Characterization
Refine candidate performance through rational strain engineering, pathway tuning, construct design, expression assessment, and functional optimization. Study plans consider intended biological activity alongside stability, growth behavior, manufacturability, and relevant safety questions, producing an auditable path from design rationale to optimized lead selection.
Explore Engineering & Optimization
Translate bench findings into a reproducible process and practical dosage concept. Our work can cover media and fermentation optimization, harvest and downstream handling, preservation strategy, excipient compatibility, dosage-form screening, and early scale-up considerations. Deliverables connect process parameters and formulation choices with viability, activity, quality, and storage goals.
Explore Process & Formulation
Generate fit-for-purpose evidence on candidate safety, biological activity, and translational relevance before clinical planning. Programs may integrate genomic safety review, phenotype-based safety assays, cell-based efficacy models, host-response endpoints, dose-range exploration, and biomarker strategy. Results are organized around explicit program risks and advancement criteria.
Explore Safety & Efficacy Assessment
Evaluate safety, efficacy, exposure, colonization or persistence, and mechanism-related endpoints in appropriately selected animal models. We support protocol design, model selection, dosing strategy, sample schedules, microbiological and host-response analysis, and integrated interpretation. Each study is built to answer a defined development question rather than produce disconnected endpoints.
Explore Preclinical Animal Studies
Establish a quality-control strategy that makes identity, purity, viability, potency-related function, and safety attributes traceable across development stages. Support can include method selection or development, panel design, reference controls, preliminary specifications, batch comparability, and release-testing execution, with reporting structured for efficient technical review.
Explore QC & Release Testing
Understand how storage, packaging, formulation, and handling affect a live product over time. We design real-time, accelerated, and stress-condition studies around viability, identity, purity, functional activity, appearance, moisture, and other relevant attributes. Trend analysis supports shelf-life planning, packaging decisions, study extensions, and risk-based refinement of formulations and analytical methods.
Explore Stability & Shelf Life AssessmentA stage-gated workflow keeps scientific questions, work packages, and evidence outputs connected while allowing scope to expand as the program matures.
Target product profile, intended function, risk register, existing-data review, and stage criteria.
Identity, genomic and phenotypic profiles, functional screens, safety flags, and lead ranking.
Engineering, fermentation, downstream handling, formulation, analytical strategy, and comparability.
Safety, efficacy, dose, persistence, biomarkers, and mechanism-focused study packages.
QC and stability outputs, integrated summaries, gap tracking, and pre-IND data-package recommendations.
Deliverables are configured to the program stage and designed to remain useful across technical reviews, vendor handoffs, partner discussions, and future study planning.
| Development Need | Core Outputs | Decision Value |
|---|---|---|
| Program positioning and strain strategy | Target product profile, candidate criteria, work-package map, risk register, and evidence plan | Aligns the team on what must be true before candidate and investment decisions |
| Discovery and lead selection | Identity package, genomic and phenotype summaries, functional screening data, and ranking matrix | Supports traceable lead selection and exposes characterization gaps early |
| Engineering, process, and formulation | Design records, optimization reports, process parameters, formulation screens, and preliminary control strategy | Connects biological performance with manufacturability and product stability |
| Safety, efficacy, and mechanism | Protocols, study reports, dose-response data, biomarker outputs, and integrated interpretation | Clarifies whether evidence supports advancement and which uncertainties remain |
| Quality and preclinical readiness | QC panel, method records, batch results, stability trends, gap tracker, and staged next-step plan | Creates a coherent, reviewable package for pre-IND and IND-enabling evidence planning |
The potential of probiotics and LBPs extends across immune modulation, metabolic health, neurological function, skin conditions, and other host-microbe interactions. Realizing that potential requires evidence that is strain-specific, product-relevant, reproducible, and connected to development decisions.
Well-designed functional and preclinical studies help distinguish promising activity from exploratory observations and provide a credible basis for development decisions and external communication.
Benefits cannot be assumed across related microorganisms. Identity, phenotype, function, and safety must be evaluated for the selected strain or defined consortium.
Viability alone may not capture product performance. Formulation, packaging, storage, administration, and functional activity should be considered as a connected product system.
Live microorganisms require thoughtful safety assessment, contamination controls, consistent identity, and stage-appropriate testing to support reliable batches and responsible program advancement.
We tailor scope, study depth, and documentation to the intended product, development stage, internal capabilities, and next decision point.
Integrated support for novel LBPs, from candidate discovery and product definition through preclinical validation and quality planning.
Flexible capabilities and coordinated work packages for focused teams advancing proprietary strains, consortia, or engineered candidates.
Strain selection, formulation, stability, and benefit-focused research for scientifically supported probiotic supplement programs.
Matrix compatibility, processing tolerance, viability, functional assessment, and shelf-life support for probiotic product concepts.
Research programs for livestock, aquaculture, and companion-animal probiotics, aligned with health, productivity, and sustainability goals.
Collaborative execution for microbiome studies, novel strain exploration, and mechanistic investigation of host-microbe interactions.
Choosing Creative Biolabs gives your team a coordinated scientific partner across the probiotic and LBP lifecycle. We connect technical depth with disciplined project management so results remain actionable as candidates, processes, and evidence requirements evolve.
Microbiology, molecular biology, analytics, formulation, process development, and preclinical study experience are coordinated around shared program objectives.
Capabilities span high-throughput screening, genomic analysis, functional assays, fermentation, analytical testing, and stability programs.
Connected planning reduces avoidable handoffs, exposes cross-functional dependencies, and keeps the development narrative coherent from strain to preclinical package.
Work packages are framed around intended use, program stage, technical risk, documentation needs, and the evidence expected at the next decision point.
Defined scopes, milestone reporting, transparent communication, and adaptable study planning help internal teams maintain control of priorities and timelines.
Traceable samples, fit-for-purpose methods, documented execution, and review-ready reporting are built into the delivery approach.
Share your current stage, available data, and next milestone. Our team can help define a practical starting scope and a connected route forward.
Yes. Each core service can be scoped as a focused work package. When helpful, we also map its inputs and outputs to upstream data and downstream decisions so the standalone project remains compatible with the broader development plan.
We start with an existing-data and gap review. Available reports, methods, strain records, process information, and preclinical results are mapped against the target product profile and upcoming decisions. This identifies usable evidence, comparability concerns, missing controls, and the most valuable next studies.
Helpful inputs include the intended product concept, strain or consortium information, genomic or phenotype data, functional results, engineering records, process summaries, analytical methods, formulation observations, stability data, preclinical reports, timelines, and known technical risks.
Yes. Scope can account for construct-specific characterization, genetic stability, expression or activity, strain ratios, component-specific identity, consortium interactions, manufacturing compatibility, and study designs that distinguish individual and combined effects.
Deliverables depend on scope, but commonly include protocols or plans, methods and acceptance criteria, raw-data or summary tables, analyzed results, study reports, integrated interpretations, identified limitations, and recommendations for the next development stage.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.
